Anna Koumarianou
Athens University, Greece
Efstathia Giannopoulou
University Hospital of Patras, Greece
Joanne Casey
AdAlta Pty Ltd, Australia
Klaus Bosslet
MedImmune, UK
Peter Park
ImmunoGen, Inc., USA
Stefanie Urlinger
MorphoSys AG, Germany
Steven Coats
MedImmnune, Inc., USA
Torgny Stigbrand
Umeå University, Sweden
Victor S. Goldmacher, Ph.D.
ImmunoGen, Inc., USA
Walter Schubert
University of Magdeburg, Germany
Andrew Murphy
Regeneron Pharmaceuticals, Inc., USA
Carol Wikstrand
Saba University School of Medicine, the Netherlands Antilles
Christina Kousparou
Trojantec Ltd., Cyprus
David Blakey
AstraZeneca/ MedImmune, UK
Efi Giannopoulou
University Hospital of Patras, Greece
Evangelos Briasoulis
University of Ioannina, Greece
Giovanni Paganelli
European Institute of Oncology, Italy
Jennie Mather
MacroGenics, Inc., USA
Klaus Bosslet
MedImmune, UK
Kostas Syrigos
Athens School of Medicine, Greece
Mikaela Friedman
AlbaNova University Centre, Royal Institute of Technology, School of Biotechnology, Sweden
Pablo Umaña
Glycart Biotechnology AG, Switzerland
Paraskevi Kallinteri
Medway School of Pharmacy, UK
Robert Waibel
Paul Scherer Institute, Switzerland
Roger Schibli
ETH Zürich, Switzerland
Spyros Stylianou
Trojantec Ltd., Cyprus
Stefan Dübel
Technical University of Braunschweig, Germany
Steven Rust
MedImmune, UK
Torgny Stigbrand
Umeå University, Sweden
Uwe Zangemeister-Wittke
University of Bern, Switzerland